Lithium 4,6-dichloropyridazine-3-carboxylate is a chemical compound that serves as a pharmaceutical intermediate. It is specifically used in the manufacturing process of deucravacitinib.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 2245238-80-4
4,6-Dichloro-pyridazine-3-carboxylic acid lithium salt monohydrate
pharmaceutical intermediate
Methyl 4,6-dichloropyridazine-3-carboxylate
Pharmaceutical intermediate for deucravacitinib
6-(Cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)pyridazine-3-carboxylic acid
Pharmaceutical intermediate for deucravacitinib
(2-Amino-5-nitrophenyl)(2-chlorophenyl)methanone Phthalimido
Pharmaceutical impurity reference standard
(2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methanol hydrochloride
pharmaceutical intermediate
4-Amino-3-fluoropyridine
Pharmaceutical intermediate for BACE1 inhibitors
Py-MAA-Val-Cit-PAB-MMAE
antibody-drug conjugate linker payload
4,6-dichloropyridazine-3-carboxylic acid
pharmaceutical intermediate
lithium 4,6-dichloropyridazine-3-carboxylate
DAHURLFXBYFSFD-UHFFFAOYSA-M
[Li+].C1=C(C(=NN=C1Cl)C(=O)[O-])Cl
—